Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Metsera, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Janus Henderson Group PLC (filed 2025-11-14).
Who is behind it
Metsera, Inc.: incorporated in Delaware; business address in New York, New York; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-02-17).
Officers and directors, each with the role and the filing that names them:
- Christopher Whitten Bernard: Executive Officer, Director (Form D, 2024-11-20)
- Clive A. Meanwell: Director (Form D, 2024-11-20)
- Paul L. Berns: Director (Form D, 2024-11-20)
- Kristina Burow: Director (Form D, 2024-11-20)
- Joshua Pinto: Director (Form D, 2024-11-20)
- Christopher J. Visioli: Executive Officer (Form D, 2024-11-20)
- Steven Marso: Executive Officer (Form D, 2024-11-20)
- Brian Hubbard: Executive Officer (Form D, 2024-11-20)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-02-17 | Janus Henderson Group PLC | 3.1% |
| Schedule 13G/A, 2025-11-17 | Fmr LLC | 0% |
| Schedule 13D/A, 2025-11-14 | Arch Venture Fund Xii, L.P. | 0% |
| Schedule 13G, 2025-11-14 | Janus Henderson Group PLC | 5.1% |
| Schedule 13G/A, 2025-11-13 | Population Health Partners, L.P. | 0% |
| Schedule 13G, 2025-10-31 | The Vanguard Group | 5.53% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-11-20 | $215M | $215M |
Latest IPO step: Metsera, Inc. filed its final IPO prospectus (424B4, 2025-01-31).
IPO filings: 424B4, 2025-01-31, S-1/A, 2025-01-27, S-1, 2025-01-10.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2025-11-13).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/metsera